Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Go back to Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors| (NASDAQ: LEGN) | Delayed: 23.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.53 | 52 Week High | $ | |||
| Open | $23.31 | 52 Week Low | $ | |||
| Day High | $24.05 | P/E | N/A | |||
| Day Low | $23.16 | EPS | $ | |||
| Volume | 943,630 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 27.02 -0.62 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.64 | 52 Week High | $117.12 | |||
| Open | $27.28 | 52 Week Low | $46.52 | |||
| Day High | $28.05 | P/E | N/A | |||
| Day Low | $27.00 | EPS | $-1.97 | |||
| Volume | 1,888,467 | |||||
